AI Topic
AI in hospitals, diagnostics, drug discovery, health-tech. Curated and summarized from dozens of sources by AIBriefs.
An analysis from Healthcare IT Today argues that human-in-the-loop oversight is not enough for safe agentic AI in healthcare, citing the need for new guardrails. The piece draws on discussions at eHealth26, including insights from Julia Zarb.
Rhapsody Axon is an AI integration agent embedded in Rhapsody and Corepoint platforms, designed to accelerate work for integration teams. It was highlighted as a notable AI tool in healthcare IT.
A new benchmark study compares clinical large language models from OpenEvidence, Doximity, and UpToDate against generalist Big Tech models to evaluate accuracy and trustworthiness. The study addresses the lack of direct comparisons despite widespread adoption by hundreds of thousands of U.S. doctors.
NVIDIA presents a developer's guide to building an AI-native digital health stack at GTC SJ 2026, focusing on interoperable architectures with generative reasoning and advanced speech.
NVIDIA introduced GPU-native medical physics simulation for healthcare robotics training and Cosmos-H-Dreams, a generative real-time simulator for surgical robotics. These tools address the data scarcity challenge in healthcare robotics by enabling realistic simulation without relying on real-world data collection.
ENvue Medical unveiled ENvue Drive, a robotic-assisted tool for automatically placing feeding tubes, built on its electromagnetic navigation platform.
Article argues that actuarially engineered AI is essential to balance risk and reward in value-based care, citing a summit of over 150 payer and provider leaders.
Based on Qwen3.6-27B, the model is designed for professional medical reasoning, medical genetics, and clinical knowledge, fine-tuned on a large-scale dataset of 370,000 high-quality QA examples.
A new fine-tuning recipe improves pathology foundation models' robustness to scanner and staining variability across laboratories.
Researchers at University of Pittsburgh used Meta's SAM3 and DINO models to develop an advanced AI-powered wheelchair, showcased in a Meta video.
Guardoc uses Amazon Nova models to process medical documents, reducing fragmentation and errors in clinical documentation.
Healthcare organizations are adopting AI too quickly without proper safeguards, risking compliance liabilities and operational issues, warns governance expert Patrick Lo in an interview.
Guest article explores how healthcare and life sciences organizations are adopting AI with a focus on data control and precision infrastructure, differing from other industries.
An analysis from The Medical Futurist explores whether AI and digital health improve health equity, concluding the answer is not simple. The TL;DR suggests digital health can help, but highlights complexities and potential downsides.
CARPL.ai raised $10M in funding led by IFC to accelerate global healthcare AI adoption. The company operates the world's largest radiology AI marketplace.
Since the 1950s, the cost of developing new drugs has doubled roughly every nine years, with failure rates above 90% and costs reaching $1B–$2.5B. AI is shifting drug discovery from empirical screening to predictive design, but requires robust data and lab integration.
Published in Nature Medicine on July 27, 2026, the piece argues existing benchmarks for medical AI are misleading and insufficient, calling for a rigorous task-based framework to define and measure AI superintelligence in medicine.
The talk details SonderMind's evals-driven development of a Mental Health AI Coach, using a clinical feedback loop with human therapists. It emphasizes balancing effectiveness and safety in AI mental health applications.
Johnson & Johnson MedTech won FDA de novo authorization for its Ottava surgical robot, the first with four robotic arms emerging from under the operating table. The system was unveiled after years of development.
NVIDIA showcases Holoscan and agentic frameworks for next-generation surgical robots at GTC SJ 2026, aiming to improve outcomes across healthcare.
Neuralink demonstrated that its brain implant enables paralyzed users to control a wheelchair using only thought, as shown in a new video from the company's clinical trial. The participants used the N1 implant to navigate a wheelchair, showcasing potential assistive applications.
Retina4IRD, an AI-based clinical decision support system, achieved 88.5% accuracy in diagnosing inherited retinal diseases in a multicenter randomized trial published in Nature Medicine. The system integrates multimodal imaging and clinical data to aid clinician diagnosis.
By 2030, one in five Americans will be over 65, with a severe caregiver shortage. AI could help older adults live independently through better voice interfaces, monitoring, and robotics.
The Department of Health and Human Services, alongside the White House, plans to bring together experts to develop standards for clinical AI. The initiative aims to address safety and efficacy benchmarks for AI in healthcare.
AI is helping design biologic medicines by optimizing engineered therapies, reducing the time and cost of drug development. The article explores how these AI models address the failure-prone nature of drug discovery.
U.S. users can now connect Apple Health and medical records to ChatGPT for personalized health insights and trend tracking. OpenAI VP Ashley Alexander says the models can understand medical context more accurately.
Google Research introduces SymptomAI, a conversational AI agent for everyday symptom assessment. The system incorporates responsible AI principles and leverages natural language processing for health-related conversations.
Alex LeBrun of Nabla explains the concept of 'world models' in an interview for STAT's AI Prognosis newsletter. The piece explores how world models differ from traditional AI and their potential in healthcare.
Medtronic announced Touch Surgery Aide, an AI compute platform that powers the Touch Surgery Ecosystem for operating rooms. The platform aims to connect surgical workflows with AI insights.
An opinion piece in STAT News notes AI is widely used in U.S. hospitals for clinical notes, sepsis flags, and imaging, but governance and CEO oversight lag behind adoption. The authors call for clearer accountability structures to prevent drift.
X-Cell model's test loss flatlines after 1.5B parameters while training loss drops, suggesting data information limits scaling. The model is developed by Xaira for drug discovery, discussed by Chief Discovery Officer Bo Wang and Chief AI Scientist Ci Chu.
HCTec uses AI to review all service calls, transforming the IT service desk from reactive to a source of operational intelligence. The AI analyzes 100% of calls, providing insights previously impossible at scale. This shift enables healthcare institutions to proactively address issues and improve patient experience.
Dylan Abrams, Lead Clinical Psychologist at InStride Health, argues that evaluating AI for mental health care should focus on clinical outcomes rather than user engagement or workflow efficiency alone. He outlines key criteria including diagnostic accuracy, safety protocols, and integration with existing care pathways.
Anthropic is expanding its role in rare disease drug development, as reported by STAT News. The move signals deeper involvement in the biotech and pharmaceutical sectors.
Trase raised $107 million in seed funding. The round was led by ARCH Venture Partners.
Samsung launched Health Assistant, an AI virtual companion that uses data from Galaxy smartphones to deliver personalized wellness insights. The launch adds to a growing market of tech companies offering AI-driven health chatbots.
Precision Neuroscience achieved thought-controlled cursor control, gaming, and smartphone navigation using its minimally invasive BCI in able-bodied individuals. The implant connects AI with human intelligence.
BrainCo demonstrated a brain-computer interface platform enabling neural control of robots, after over a decade of development. The system, shown at the 2026 World AI Conference, also includes an AI-powered bionic hand with independent finger control.
Researchers can receive up to $50,000 in Claude credits over six months. Two tracks: one for basic research and one for early-stage biotechs accelerating clinical development for rare diseases.
A healthcare provider reported an improved EHR experience score following deployment of an AI tool. The score reflects enhanced clinical workflows and reduced administrative burden.
Anthropic CEO Dario Amodei, a former biologist, recounted cases where AI diagnosed complex medical issues that puzzled specialists. He argues that AI's most transformative impact is currently in biology and medicine labs.
Bristol Myers Squibb announced it is deploying its second NVIDIA DGX SuperPOD with Vera Rubin NVL72 systems, calling it the 'SuperDuperPOD'. The company claims it will be the most powerful AI factory in life sciences, though STAT notes this is the third pharma company in nine months to make such a claim.
Anant Shankhdhar presents four AI agents that handle different steps of oncology workflows end-to-end, passing outputs without human intervention. The agents combine to automate the entire process from start to finish.
Article explores the potential of AI to streamline or complicate prior authorization in healthcare. It highlights patient struggles with the current system and questions whether AI will improve outcomes or create new barriers.
ZUNA1.1 is released under Apache 2.0, supporting variable-length inputs from 0.5 to 30 seconds across arbitrary channel layouts. It builds on ZUNA1 with improved flexibility for reconstruction, denoising, and upsampling of EEG data.
Veristat's VP of AI Innovation discusses InStat, the first zero-code, fully automated biostatistics solution for clinical trials. The tool aims to reduce manual biostatistical analysis readouts in life sciences research.
Prosper AI raised $30 million from Andreessen Horowitz to scale its AI platform that manages the entire patient journey. The platform is already working across 150,000 healthcare encounters.
Biomni performs research tasks across diverse biomedical fields. The AI agent, described in Nature Medicine, could be a powerful research partner for scientists.
The platform integrates Databricks' data lakehouse with Dotmatics Luma to bridge the gap between experimental data and AI-driven insights. It aims to accelerate scientific discovery in healthcare and life sciences by making data AI-ready.
The multi-year collaboration will evaluate how providers' AI use at the point of care correlates with care delivery patterns. The study aims to measure AI's effect on clinical outcomes and efficiency.
Sequoia announces partnership with Bunkerhill Health, an AI agent platform covering clinical, operational, and administrative functions. Founders Nish Khandwala and David Eng are building the platform to improve patient outcomes.
AI in radiology still requires human oversight due to potential mistakes. The article explores the symbiotic relationship and underscores that AI is not replacing radiologists but augmenting them.
CMS signaled intent to build a consistent payment structure for clinical AI tools in its proposed 2027 rules. The agency is starting with a practical change to labeling and payment for several clinical software and AI services.
Neko Health raised $700 million in Series C funding for its AI-powered full-body health scan service. Lightspeed Venture Partners and O.G. Venture Partners co-led the round, with participation from General Catalyst, Atomico, Lakestar, and Liberty Mutual.
A whistleblower lawsuit has been filed involving Mayo Clinic, Sutter Health, and Abridge, an AI medical scribe company. The case, covered in STAT's AI Prognosis newsletter, highlights concerns over AI in healthcare.
HIMSS TV features a video on using AI for delirium detection and reduction. The technology aims to improve patient outcomes through early intervention.
Sahay argues that vision-language models (VLMs) can outperform OCR for parsing paper healthcare documents into EDI claims, noting that 98% of claims are electronic but many still rely on error-prone OCR. VLMs better handle complex layouts and ambiguous text, potentially reducing processing errors.
Founded by Gidi Littwin, Hemispheric aims to make diagnostic brain scans using AI as cheap and easy as a blood test. The technology targets conditions like depression, PTSD, and Parkinson's.
Lightspeed is in discussions to lead the funding round for the venture, which would focus on AI-driven drug discovery. Wang is a researcher at OpenAI known for contributions to language models.
Researchers at QIMR Berghofer developed STimage, a machine learning tool that applies spatial analysis to H&E-stained tissue samples to help pathologists identify subtle cancer biomarkers. The tool will be trialed in Queensland pathology labs.
Flo Health's engineering team turned a proof of concept from the AWS Generative AI Innovation Center into a production-grade medical content review system. The system uses Amazon Bedrock to scale operations.
The solution uses Amazon Nova Sonic for voice and Amazon Bedrock Guardrails for compliance. It targets the growing AI patient scheduling market.
The startup raised $32.5 million in seed and Series A funding, led by Oak HC/FT. Corner Health's platform enables nurse practitioners to run independent primary care practices using AI.
The video discusses how healthcare organizations can use key performance indicators (KPIs) to guide the adoption of artificial intelligence. It provides a framework for measuring success and aligning AI initiatives with organizational goals.
Callie Care, a phone-first voice AI startup, raised $500K pre-seed to address the senior care gap. The funding round aims to expand its AI-powered senior care platform.
Results from the OpenADMET competition indicate that larger AI models do not consistently outperform smaller ones in predicting drug metabolism. This finding challenges the prevailing assumption that scale always improves performance in biomedical AI.
An opinion piece describes a scenario where a patient sees a deepfake video of her doctor endorsing a hormone supplement and dismissing standard therapies. The author warns that such AI-generated videos could undermine trust in medical advice and require regulation.
National Heart Centre Singapore (NHCS) developed CARDIA-GM, a machine learning platform that assesses heart muscle damage after a heart attack in 60 seconds. It helps doctors identify high-risk patients for future cardiac events.
A video from HIMSS TV examines an AI-powered healthcare ecosystem in Europe. It outlines the ecosystem's components and the lessons it provides for broader European adoption. The coverage focuses on practical insights from the deployment.
Massive Bio, which uses AI to identify cancer patients eligible for clinical trials, is partnering with patient advocacy group Sequence Me Now. The collaboration will link resources on both organizations' websites to expand trial access.
Overall trust in AI for healthcare fell to 44% in 2026, down from 52% in 2024, per new digital health research. Only 14% of Americans currently use AI for health and wellness.
Queue's $18.6M-backed kiosk dispenses 600 pills per minute in a Palo Alto pilot. Queue plans broader rollout by early 2027.
The iLENS framework integrates a mixture-of-experts architecture with LLM guidance for neuroimaging-based survival analysis, predicting Alzheimer's disease conversion during the prodromal stage. It achieves improved interpretability and predictive performance on longitudinal brain imaging data.
Researchers cobbled together funding to show how quantum computing and AI can generate novel peptides for drug development. The work targets underserved populations and rare diseases.
OpenEvidence, an AI-driven clinical decision support tool, partners with NewYork-Presbyterian, Columbia Vagelos College of Physicians and Surgeons, and Weill Cornell Medicine to expand access across NYC medical centers. The collaboration aims to bring AI-powered clinical insights to more healthcare providers in the region.
Up to 20% of insurance claims are initially denied due to missing or low-quality images. Amazon SageMaker AI enables real-time verification at the point of capture. A clinician reviews X-rays to ensure quality before submission.
A HIMSS TV video argues that return on investment is an incomplete measure for evaluating healthcare AI. It calls for broader metrics like clinical outcomes and patient experience.
SensorFM is pre-trained on over 1 trillion minutes of sensor data across 35 health endpoints. It addresses label scarcity by learning from raw data and can be fine-tuned for multiple downstream health tasks.
A systematic audit of 27 papers on colonoscopy polyp segmentation reveals that progress is difficult to verify due to inconsistent evaluation metrics and reporting. The authors call for standardized benchmarks to ensure reliable comparisons.
Paper evaluates federated learning approaches on multi-organ medical images to address privacy and data heterogeneity. Provides a benchmark for future medical AI models.
NeuroVFM, a model trained on routine MRI and CT scans from health systems, improves diagnosis, report generation, and triage. The study demonstrates how private clinical data can power safer, more generalizable neuroimaging AI.
Cataracts are the world's leading cause of blindness, treatable only by surgery, but there is a shortage of trained surgeons. ForSight Robotics is developing a fully robotic system to address this, with Dr. Robert Ang as principal investigator.
OntarioMD leaders discuss moving past AI hype and deploying practical AI without disrupting clinical care. They emphasize the need for effective data standards and interoperability to enable real-world use.
OpenMed 1.8 adds Android, iOS, and browser support for local clinical de-identification, with no cloud calls. The open-source toolkit has over 400 open issues for the upcoming 1.9 release.
Hospitals are abandoning EHR migrations due to massive capital costs and multi-year timelines. Instead, they are keeping current systems and redirecting investment toward AI initiatives.
The partnership integrates Cortechs.ai's quantitative MRI analysis into Viz.ai's AI-powered care coordination platform, starting with multiple sclerosis. The goal is to help clinicians identify and manage patients with neurodegenerative disease more effectively.
The model is a fine-tune of Qwen3.5-27B for medical reasoning, reportedly outperforming MedGemma. Available on Hugging Face under EpistemeAI/Reasoning-Medical0.1-27B.
January AI's Clinician Nutrition Monitor, an EHR-native tool, has been qualified on the Mayo Clinic Platform for integration into Epic clinical workflows. The AI-powered tool provides nutrition insights directly to clinicians at the point of care.
The AWS AI Blog walks through using BYOKG and GraphRAG with Amazon Bedrock and Neptune to unify scattered pharmaceutical data for more efficient drug discovery. The technique integrates internal lab notes, published literature, and genomics databases.
Pearl Health, a healthcare outcomes platform for Medicare patients, raised $110 million in capital including a $50 million equity round led by Andreessen Horowitz. The company reached profitability in 2025.
A cardiologist reviews an echocardiogram flagged by an unfamiliar algorithm deployed by her health system. She disagrees, overrides it, and the patient does well — illustrating why licensure debates miss the mark on physician responsibility.
A retired minister named Doug finds companionship in an AI chatbot, Jane, as his wife observes. The opinion piece questions whether AI can properly fill the social needs of dementia patients.
A video from HIMSS TV covers research showing that connections with therapeutic robots can lower patient stress levels. The findings highlight potential benefits of robotic companions in healthcare settings.
Brook.ai partners with SRHO, representing 275+ hospitals across 20 states, to deploy an AI-enabled remote care platform. The platform combines clinician-governed workflows with AI to support chronic care management.
A video from HIMSS TV explores how AI tools can shift healthcare from reactive to proactive care models. The discussion covers potential applications in predicting patient needs and enabling early interventions.
The orbital lab will transmit data to train AI models for predicting protein behavior linked to Alzheimer’s and cancer. This mission aims to leverage microgravity to accelerate biological research that is difficult to conduct on Earth.
Tutorial walks through building an AI co-scientist using ChEMBL, RDKit, SHAP, and BRICS for discovering EGFR inhibitors targeting the C797S osimertinib-resistant mutation in non-small cell lung cancer. Covers scaffold-splitting, random forest QSAR modeling, and explainable AI with SHAP.
The Department of Health – Abu Dhabi and MIT's Koch Institute for Integrative Cancer Research will collaborate on AI-enabled oncology research. The partnership aims to combine MIT's research expertise with Abu Dhabi's healthcare resources to accelerate cancer diagnosis and treatment development.
In a video interview, Commure executive explores using ambient AI technology for Ebola tracking and public health surveillance. The discussion focuses on real-time data collection and response.
Amodei said his vision for AI in biotech may take a decade to materialize. He discussed the timeline during an on-stage conversation, referencing his 2024 essay 'Machines of Loving Grace'.
The AI-powered smartphone app helps hospital staff decide whether to admit a sick child for emergency care. It addresses overcrowding and a shortage of child specialists in South Korean hospitals.
NVIDIA CEO Jensen Huang explains why radiology could become one of the first professions transformed by AI, citing computer vision advancements in healthcare. He emphasizes that AI will not eliminate radiologists but change how they work.
A behind-the-scenes video reveals the scanner as 'scores of ultrasound probes hacked apart and slapped on a hot tub.' Experts say Midjourney has shown little evidence it can overcome ultrasound's limits. The company plans to launch as a wellness product focused on body composition, avoiding FDA clearance.
The toolkit enables AI agents to perform hands-on scientific work using real scientific software, moving beyond conversational Q&A. It targets drug discovery and molecular research with agentic capabilities.
A Vancouver police sergeant is the first Canadian ALS patient to receive a Neuralink brain-computer implant. The surgery used a new experimental robot that inserted electrode strands through the brain's dura.
Sword Health will make its AI-enabled musculoskeletal care platform available through Portugal's public health system (SNS). Physicians can prescribe the remote physiotherapy program to patients.
A CDC study showed healthcare burnout rate at 46% and turnover at 44% in 2023. AI-powered revenue cycle tools from companies like CodaMetrix, RevSpring, and Zelis aim to reduce administrative burden and improve staff retention.
UpDoc's diabetes app became the first FDA-cleared medical software to use patient-facing large language models. The clearance sparks debate over whether LLMs should serve as interface or decision-maker.
A new JAMA Pediatrics study finds the share of teens using AI chatbots for mental health rose from 1 in 8 to 1 in 5 in one year. The author calls for proactive regulation, citing lawsuits linking chatbots to teen suicides and other harms.
Explores AI applications in pre-clinical drug development, highlighting how machine learning models accelerate target identification and lead optimization. Covers challenges in data quality and model interpretability.
Thirteen new papers on medical image analysis were posted on arXiv, covering mammography (AEGIS, MammoFlow), histopathology, segmentation, and clinical hallucination detection. Methods include vision transformers, diffusion models, and reinforcement learning.
Nature Medicine reports that LLMs achieving high scores on health benchmarks fail adversarial stress tests, exposing shortcut reliance and fragile visual grounding. The findings suggest current evaluations overstate application readiness for clinical settings.
Proto is the first programming language designed specifically for generative biology. It aims to accelerate research in smart medicine and cancer therapies.
OpenLoop, a digital health staffing and support company, acquired Hey Revia, a voice AI platform that handles complex phone calls for healthcare providers. OpenLoop offers an infrastructure telehealth platform alongside regulatory and legal support for virtual care.
In a STAT newsletter, reporter Brittany Trang recounts the experience that convinced her Anthropic is serious about AI in science. The piece highlights Claude's potential in healthcare and life sciences.
Latent Space podcast interviews Evan Feinberg and Sergey Edunov about diffusion models for molecular generation. The discussion covers their work at Genesis Molecular AI, a startup applying these techniques to drug discovery.
Microsoft's Dragon Copilot ambient AI transcription tool aims to reduce clinical documentation burden for rural providers. The article notes rural hospitals face unique challenges including tech debt, variable reimbursement, and limited IT support.
A HIMSS TV video on MobiHealthNews discusses how AI will shape the future healthcare workforce. The piece emphasizes the need for AI integration in training and practice. No specific statistics or examples are provided.
A MobiHealthNews video article argues that standardizing health data is crucial for AI adoption in Spain's healthcare system. It highlights the need for interoperable data to enable AI-driven diagnostics and personalized treatment.
The tool helps users understand symptoms, check insurance eligibility, and find care options. It is powered by AWS cloud infrastructure.
In an interview, Capital Area Health Network CEO Tracy Causey explains how AI call automation reduced hold times and staff burnout at three sites serving 17,000 patients. The approach integrates with the existing EHR system to streamline patient communication.
FDA's digital health leader signaled forthcoming policy updates for AI in health tech. The updates are expected to address AI regulation in medical devices and clinical settings.
Jon and Mindy Gray are investing in AI science research aimed at preventing cancer. The specific amount and projects were not disclosed.
Claude Science provides 60+ scientific databases and integrates with NVIDIA BioNeMo Agent Toolkit for accelerated life sciences research. Anthropic also announced an internal AI drug discovery program using the platform.
In retrospective, external, and prospective evaluations, a case-grounded LLM agent demonstrated high concordance with hematology tumor board decisions for clinical decision support. The locally deployable system integrates patient case context to aid in hematological malignancy management.
Two agentic AI models, AMIE and MIRA, could aid diagnosis, treatment, and hospital admission decisions. However, neither model is yet ready for clinical use, according to a Nature Medicine research highlight.